Mycobacterium abscessus Complex – a Particular Challenge in the Setting of Lung Transplantation

References

• Yusen RD, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report – 2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33:1009.
   PubMed Web of Science ®Google Scholar
• Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.
   PubMed Web of Science ®Google Scholar
• Moore M, Frerichs JB. An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, Mycobacterium abscessus, n. sp. J Invest Dermatol. 1953;20:133–169.
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Ezaki T. Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov. Int J Syst Bacteriol. 1992;42:240–245.
   PubMedGoogle Scholar
• Kirschner P, Roseau J, Springer B, et al. Diagnosis of mycobacterial infection by nucleic acid amplification: 18-month prospective study. J Clin Microbiol. 1996;34:304–312.
   PubMed Web of Science ®Google Scholar
• Adékambi T, Berger P, Raoult D, et al. rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp.nov. Int J Syst Bacteriol. 2006;56:133–143.
   Google Scholar
• Adékambi T, Reynaud-Gaubert M, Greub G, et al. Amoebal co-culture of ‘Mycobacterium massiliense sp. nov. from the sputum of a patient with hemoptoic pneumonia. J Clin Microbiol. 2004;42:5493–5501.
   PubMed Web of Science ®Google Scholar
• Viana-Niero C, Lima KVB, Lopes ML, et al. Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after laparoscopic surgeries and cosmetic procedures. J Clin Microbiol. 2008;46:850–855.
   PubMed Web of Science ®Google Scholar
• Kim HY, Yun YJ, Chan GP, et al. Outbreak of Mycobacterium massiliense infection associated with intramuscular injections. J Clin Microbiol. 2007;45:3127–3130.
   PubMed Web of Science ®Google Scholar
• Lyu J, Kim B-J, Kim B-J, et al. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease. Respir Med. 2014;108:1706–1712.
   PubMed Web of Science ®Google Scholar
• Morales P, Gil A, Santos M. Mycobacterium abscessus infection in transplant recipients. Transplant Proc. 2010;42:3058–3060.
   PubMed Web of Science ®Google Scholar
• Field SK, Cowie RL. Lung disease due to the more common nontuberculous mycobacteria. Chest. 2006;129:1653–1672.
   PubMed Web of Science ®Google Scholar
• Olivier KN, Weber DJ, Wallace RJ Jr, et al. Nontuberculous mycobacteria 1: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003;167:828–834.
   PubMed Web of Science ®Google Scholar
• Lai CC, Tan CK, Chou CH, et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis. 2010;16:294–296.
   PubMed Web of Science ®Google Scholar
• Moore JE, Kruijshaar ME, Ormerod LP, et al. Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995–2006. BMC Public Health. 2010;10:612–617.
   PubMed Web of Science ®Google Scholar
• Bar-On O, Mussaffi H, Mei-Zahav M, et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis. Journal Cyst Fibros. 2015;14:53–62.
   PubMed Web of Science ®Google Scholar
• Kendall BA, Winthrop KL. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013;34:87–94.
   PubMed Web of Science ®Google Scholar
• Haverkamp MH, Van Dissel JT, Holland SM. Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-γ-dependent signaling. Microbes Infect. 2006;8:1157–1166.
   PubMed Web of Science ®Google Scholar
• Feazel LN, Baumgartner LK, Peterson KL, et al. Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci USA. 2009;106:16393–16399.
   PubMed Web of Science ®Google Scholar
• Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev. 2004;17:57–71.
   PubMed Web of Science ®Google Scholar
• Falkinham JO 3rd. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis. 2011;17:419–424.
   PubMed Web of Science ®Google Scholar
• Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med. 1999;160:1611–1616.
   PubMed Web of Science ®Google Scholar
• Chalermskulrat W, Sood N, Neuringer IP, et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax. 2006;61:507–513.
   PubMed Web of Science ®Google Scholar
• Kesten S, Chaparro C. Mycobacterial infections in lung transplant recipients. Chest. 1999;115:741–745.
   PubMed Web of Science ®Google Scholar
• Longworth SA, Vinnard C, Lee I, et al. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case–control study. Transpl Infect Dis. 2014;16:76–83.
   PubMed Web of Science ®Google Scholar
• Knoll BM, Kappagoda S, Gill RR, et al. Non-tuberculous mycobacterial infection among lung transplant recipients: A 15-year cohort study. Transpl Infect Dis. 2012;14:452–460.
   PubMed Web of Science ®Google Scholar
• Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med. 2002;23:553–567.
   PubMed Web of Science ®Google Scholar
• Sanguinetti M, Ardito F, Fiscarelli E, et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol. 2001;39:816–819.
   PubMed Web of Science ®Google Scholar
• Huang HC, Weigt SS, Derhovanessian A, et al. Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality. J Heart Lung Transplant. 2011;30:790–798.
   PubMed Web of Science ®Google Scholar
• Borro JM. Advances in immunosuppression after lung transplantation. Med Intensiva. 2013;37:44–49.
   PubMed Web of Science ®Google Scholar
• Huang HJ, Yusen RD, Meyers BF, et al. Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant. 2008;8:2454–2462.
   PubMed Web of Science ®Google Scholar
• Daud SA, Yusen RD, Meyers BF, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2007;175):507–513.
   PubMed Web of Science ®Google Scholar
• Falkinham JO, Norton CD, Lechevallier MW. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare and other mycobacteria in drinking water distribution systems. Appl Environ Microbiol. 2001;67:1225–1231.
   PubMed Web of Science ®Google Scholar
• Thomson R, Tolson C, Carter R, et al. Isolation of nontuberculous mycobacterium (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM. J Clin Microbiol. 2013;51:2006–3011.
   PubMed Web of Science ®Google Scholar
• Koh SJ, Song T, Kang YA, et al. An outbreak of skin and soft tissue infection caused by Mycobacterium abscessus following acupuncture. Clin Microbiol Infect. 2010;16:895–901.
   PubMed Web of Science ®Google Scholar
• Wallace RJ Jr, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol. 1998;52:453–490.
   PubMed Web of Science ®Google Scholar
• Bryant JM, Grogono DM, Greaves D, et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: A retrospective cohort study. Lancet. 2013;381:1551–1560.
   PubMed Web of Science ®Google Scholar
• Böttger EC. Transmission of M. abscessus in patients with cystic fibrosis. Lancet. 2013;382:503–504.
   PubMed Web of Science ®Google Scholar
• Bange FC, Brown BA, Smaczny C, et al. Lack of transmission of Mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. Clin Infect Dis. 2001;32:1648–1650.
   PubMed Web of Science ®Google Scholar
• Harris KA, Underwood A, Kenna DT, et al. Whole-genome sequencing and epidemiological analysis do not provide evidence for cross-transmission of Mycobacterium abscessus in a cohort of pediatric cystic fibrosis patients. Clin Infect Dis. 2015;60:1007–1016.
   PubMed Web of Science ®Google Scholar
• Standards for the Clinical Care of Children and Adults with Cystic Fibrosis in the UK. 2nd ed. [ updated 2011 Dec; cited 2015 Oct 23]. Available from: http://www.cysticfibrosis.org.uk/media/448939/cd-standards-of-care-dec-2011.pdf.
   Google Scholar
• Saiman L, Siegel JD, LiPuma JJ, et al. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol. 2014;35(Suppl 1):51–67.
   Google Scholar
• Bills H, Snell G, Levvey B, et al. Mycobacterium abscessus and lung transplantation: an international survey. J Heart Lung Transplant. 2015;34:S304.
   Google Scholar
• Van Ingen J, De Zwaan R, Dekhuijzen RPN, et al. Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients. J Infect. 2009;59:324–331.
   PubMed Web of Science ®Google Scholar
• Lee MR, Yang CY, Chang KP, et al. Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease. PLoS ONE. 2013;8:e58214.
   Google Scholar
• Knoll BM. Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients. Curr Infect Dis Rep. 2014;16:421–431.
   PubMed Web of Science ®Google Scholar
• Chernenko SM, Humar A, Hutcheon M, et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience. J Heart Lung Transplant. 2006;25:1447–1455.
   PubMed Web of Science ®Google Scholar
• Wentworth AB, Drage LA, Wengenack NL, et al. Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: A population-based study. Mayo Clin Proc. 2013;88:38–45.
   PubMed Web of Science ®Google Scholar
• Nessar R, Cambau E, Reyrat J, et al. Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother. 2012;67:810–818.
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae and other aerobic actinomycetes; approved standard. 2nded. CLSI document No. M24-A2, Wayne, PA, USA: CLSI; 2011.
   Google Scholar
• Nash KA, Brown-Elliot BA, Wallace RJ Jr. A novel gene, erm(41) confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009;53:1367.
   PubMed Web of Science ®Google Scholar
• Van Ingen J, Boeree MJ, Van Soolingen D, et al. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat. 2012;15:149–161.
   PubMed Web of Science ®Google Scholar
• Bastian S, Veziris N, Roux AL, et al. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother. 2011;55:775–781.
   PubMed Web of Science ®Google Scholar
• Choi GE, Shin SJ, Won CJ, et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Resp Crit Care Med. 2012;186:917–925.
   PubMed Web of Science ®Google Scholar
• Shallom SJ, Gardina PJ, Myers TG, et al. New rapid scheme for distinguishing the subtypes of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible macrolide resistance. J Clin Microbiol. 2013;51:2943–2949.
   PubMed Web of Science ®Google Scholar
• Broda A, Jebbari H, Beaton K, et al. Comparative drug resistance of Mycobacterium abscessus and M. chelonae. Antimicrob Agents Chemother. 2009;51:217–223.
   Google Scholar
• Taylor JL, Palmer SM. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. J Heart Lung Transplant. 2006;25:985–988.
   PubMed Web of Science ®Google Scholar
• Lobo LJ, Chang LC, Esther CR, et al. Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections. Clin Transplant. 2013;27:523–529.
   PubMed Web of Science ®Google Scholar
• Robinson PD, Harris KA, Aurora P, et al. Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species. Eur Respir J. 2013;41:1230–1232.
   PubMed Web of Science ®Google Scholar
• Qvist T, Pressler T, Thomsen VO, et al. Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population. Transplant Proc. 2013;45:342–345.
   PubMed Web of Science ®Google Scholar
• Zaidi S, Elidemir O, Heinle JS, et al. Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence. Transpl Infect Dis. 2009;11:243–248.
   PubMed Web of Science ®Google Scholar
• Benwill JL, Wallace RJ Jr. Mycobacterium abscessus: challenges in diagnosis and treatment. Curr Opin Infect Dis. 2014;27:506–510.
   PubMed Web of Science ®Google Scholar
• Wallace RJ Jr, Dukart G, Brown-Elliott BA, et al. Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections. J Antimicrob Chemother. 2014;69:1945–1953.
   PubMed Web of Science ®Google Scholar
• Van Ingen J, Totten SE, Helstrom NK, et al. In vitro synergy between clofazimine and amikacin in treatment of non-tuberculous mycobacterial disease. Antimicrobial Agents Chemother. 2012;56:6324–6327.
   PubMed Web of Science ®Google Scholar
• Olivier KN, Shaw PA, Glaser TS, et al. Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. Ann Am Thorac Soc. 2014;11:30–35.
   PubMedGoogle Scholar
• Huitric E, Verhasselt P, Andries K, et al. In vitro antimycobacterial spectrum of diarylquinoline ATP synthase inhibitor. Antimicrob Agents Chemother. 2007;51:4202–4204.
   PubMed Web of Science ®Google Scholar
• Philley JV, Wallace RJ Jr, Benwill JK, et al. Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease. Chest. 2015;148:499–506.
   PubMed Web of Science ®Google Scholar
• Urbina O, Ferrandez O, Espona M, et al. Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections. Drug Des Dev Ther. 2013;7:243–265.
   PubMed Web of Science ®Google Scholar
• Flanagan S, Minassian SC, Morris D. Pharmacokinetics of tedizolid in subject with renal or hepatic failure. Antimicrobial Agents Chemother. 2014;58:6471–6478.
   PubMed Web of Science ®Google Scholar
• Taramona-Espinoza C, Steed L. In vitro tedizolid minimum inhibitory concentration (MIC) against clinical isolates of M. abscessus. Abstract #581, ID Week; 2015 Oct 7–11; San Diego, USA.
   Google Scholar
• Lyu J, Jang HJ, Song JW, et al. Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs. Respir Med. 2011;105:781–787.
   PubMed Web of Science ®Google Scholar
• Jarand J, Levin A, Zhang L, et al. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis. 2011;52:565–571.
   PubMed Web of Science ®Google Scholar
• Koh WJ, Kim YH, Kwon OJ, et al. Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria. J Korean Med Sci. 2008;23:397–401.
   PubMed Web of Science ®Google Scholar
• Mitchell JD, Bishop A, Cafaro A, et al. Anatomic lung resection for nontuberculous mycobacterial disease. Ann Thorac Surg. 2008;85:1887–1893.
   PubMed Web of Science ®Google Scholar
• Shiraishi Y, Nakajima Y, Katsuragi N, et al. Pneumonectomy for nontuberculous mycobacterial infections. Ann Thorac Surg. 2004;78:399–403.
   PubMed Web of Science ®Google Scholar
• Sherwood JT, Mitchell JD, Pomerantz M. Completion pneumonectomy for chronic mycobacterial disease. J Thorac Cardiovasc Surg. 2005;129:1258–1265.
   PubMed Web of Science ®Google Scholar
• Doucette K, Fishman JA. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis. 2004;38:1428–1439.
   PubMed Web of Science ®Google Scholar
• Florescu DF, Kalil AC, Qiu F, et al. What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis. Am J Transplant. 2013;13:2601–2610.
   PubMed Web of Science ®Google Scholar
• Kwon YS, Kim EJ, Lee SH, et al. Decreased cytokine production in patients with nontuberculous mycobacterial lung disease. Lung. 2007;185:337–341.
   PubMed Web of Science ®Google Scholar
• Holland SM, Eisenstein EM, Kuhns DB, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med. 1994;330:1348–1355.
   PubMed Web of Science ®Google Scholar
• Kane CL, Vincent AL, Greene JN, et al. Disseminated cutaneous Mycobacterium chelonae infection. Cancer Control. 2000;7:181–184.
   PubMedGoogle Scholar